A Contrepois
- Epidemiology top 10%
- Infectious Diseases top 5%
- Pharmacology top 5%
- Clinical Biochemistry top 5%
- Molecular Medicine top 5%
- Topics
- Antibiotics Pharmacokinetics and Efficacy (22 papers)Antimicrobial Resistance in Staphylococcus (7 papers)Drug Transport and Resistance Mechanisms (6 papers)
- Partner nations
- France
In The Last Decade
A Contrepois
30 papers receiving 726 citations
Peers
Comparison fields: 5 of 83
- Epidemiology 424
- Infectious Diseases 385
- Pharmacology 278
- Clinical Biochemistry 122
- Molecular Medicine 110
Countries citing papers authored by A Contrepois
This map shows the geographic impact of A Contrepois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Contrepois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Contrepois more than expected).
Fields of papers citing papers by A Contrepois
This network shows the impact of papers produced by A Contrepois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Contrepois. The network helps show where A Contrepois may publish in the future.
Co-authorship network of co-authors of A Contrepois
This figure shows the co-authorship network connecting the top 25 collaborators of A Contrepois. A scholar is included among the top collaborators of A Contrepois based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Contrepois. A Contrepois is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | [The new terms of "infectious diseases": the birth of the clinical bacteriology and infectious pathology in France]. | 1 |
| 2 | 7 | |
| 3 | 23 | |
| 4 | [The birth of hemoculture]. | 4 |
| 5 | 10 | |
| 6 | 43 | |
| 7 | 22 | |
| 8 | 21 | |
| 9 | 49 | |
| 10 | 24 | |
| 11 | 192 | |
| 12 | 18 | |
| 13 | 43 | |
| 14 | 0 | |
| 15 | 5 | |
| 16 | 18 | |
| 17 | 15 | |
| 18 | 9 | |
| 19 | Tissue cage experiments with beta-lactam antibiotics in rabbits. | 10 |
| 20 | 9 |
About A Contrepois
A Contrepois is a scholar working on Pharmacology, Molecular Medicine and Clinical Biochemistry, having authored 32 papers that have together received 804 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (22 papers), Antimicrobial Resistance in Staphylococcus (7 papers) and Drug Transport and Resistance Mechanisms (6 papers). The work is most often cited by research in Molecular Medicine (110 citations), Infectious Diseases (385 citations) and Clinical Biochemistry (122 citations). A Contrepois has collaborated with scholars based in France. Frequent co-authors include C Carbon, Françoise Dromer, P. Yéni, J Charreire, N Brion, J M Vallois, Claude Carbón, Jean Salamero, B. Pangon and Laurent Abel. Their work appears in journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Infection and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.